Annual Current Assets
$580.88 M
+$91.09 M+18.60%
December 31, 2023
Summary
- As of February 7, 2025, SNDX annual total current assets is $580.88 million, with the most recent change of +$91.09 million (+18.60%) on December 31, 2023.
- During the last 3 years, SNDX annual current assets has risen by +$282.01 million (+94.36%).
- SNDX annual current assets is now at all-time high.
Performance
SNDX Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Current Assets
$414.81 M
-$31.25 M-7.01%
September 30, 2024
Summary
- As of February 7, 2025, SNDX quarterly total current assets is $414.81 million, with the most recent change of -$31.25 million (-7.01%) on September 30, 2024.
- Over the past year, SNDX quarterly current assets has increased by +$33.84 million (+8.88%).
- SNDX quarterly current assets is now -28.59% below its all-time high of $580.88 million, reached on December 31, 2023.
Performance
SNDX Quarterly Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Current Assets Formula
Current Assets = Cash and Equivalents + Accounts Receivable + Inventory + Prepaid Expenses + Marketable Securities + Other Current Assets
SNDX Current Assets Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +18.6% | +8.9% |
| 3 y3 years | +94.4% | -1.3% |
| 5 y5 years | +597.0% | -1.3% |
SNDX Current Assets Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +29.6% | -28.6% | +16.0% |
| 5 y | 5-year | at high | +831.9% | -28.6% | +565.5% |
| alltime | all time | at high | >+9999.0% | -28.6% | +7921.8% |
Syndax Pharmaceuticals Current Assets History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $414.81 M(-7.0%) |
| Jun 2024 | - | $446.06 M(-1.7%) |
| Mar 2024 | - | $453.90 M(-21.9%) |
| Dec 2023 | $32.00 M(+329.6%) | $580.88 M(+52.5%) |
| Sep 2023 | - | $380.97 M(-6.9%) |
| Jun 2023 | - | $409.08 M(-7.3%) |
| Mar 2023 | - | $441.51 M(-9.9%) |
| Dec 2022 | $7.45 M(+490.8%) | $489.79 M(+37.0%) |
| Sep 2022 | - | $357.63 M(-8.8%) |
| Jun 2022 | - | $392.29 M(-6.6%) |
| Mar 2022 | - | $420.06 M(-6.3%) |
| Dec 2021 | $1.26 M(-27.9%) | $448.40 M(+88.2%) |
| Sep 2021 | - | $238.25 M(-9.3%) |
| Jun 2021 | - | $262.56 M(-5.9%) |
| Mar 2021 | - | $278.95 M(-6.7%) |
| Dec 2020 | $1.75 M(+46.5%) | $298.86 M(+68.4%) |
| Sep 2020 | - | $177.43 M(-7.5%) |
| Jun 2020 | - | $191.81 M(+84.1%) |
| Mar 2020 | - | $104.21 M(+67.2%) |
| Dec 2019 | $1.19 M | $62.33 M(-16.7%) |
| Sep 2019 | - | $74.85 M(-12.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2019 | - | $85.78 M(-12.1%) |
| Mar 2019 | - | $97.63 M(+17.1%) |
| Dec 2018 | $592.00 K(-84.2%) | $83.35 M(-13.0%) |
| Sep 2018 | - | $95.85 M(-8.5%) |
| Jun 2018 | - | $104.70 M(-12.2%) |
| Mar 2018 | - | $119.31 M(-10.6%) |
| Dec 2017 | $3.74 M(+644.3%) | $133.44 M(+7.6%) |
| Sep 2017 | - | $123.97 M(-7.6%) |
| Jun 2017 | - | $134.17 M(+38.2%) |
| Mar 2017 | - | $97.06 M(-10.6%) |
| Dec 2016 | $503.00 K(-73.5%) | $108.51 M(-7.5%) |
| Sep 2016 | - | $117.27 M(-7.9%) |
| Jun 2016 | - | $127.38 M(-6.2%) |
| Mar 2016 | - | $135.77 M(+54.3%) |
| Dec 2015 | $1.90 M(+409.7%) | $88.01 M(-13.1%) |
| Sep 2015 | - | $101.27 M(+713.8%) |
| Dec 2014 | $372.00 K(-85.2%) | $12.44 M(+4.4%) |
| Sep 2014 | - | $11.92 M(+130.5%) |
| Jun 2014 | - | $5.17 M(-47.0%) |
| Mar 2014 | - | $9.75 M(-33.0%) |
| Dec 2013 | $2.52 M(+224.8%) | $14.54 M |
| Dec 2012 | $775.00 K | - |
FAQ
- What is Syndax Pharmaceuticals annual total current assets?
- What is the all time high annual current assets for Syndax Pharmaceuticals?
- What is Syndax Pharmaceuticals annual current assets year-on-year change?
- What is Syndax Pharmaceuticals quarterly total current assets?
- What is the all time high quarterly current assets for Syndax Pharmaceuticals?
- What is Syndax Pharmaceuticals quarterly current assets year-on-year change?
What is Syndax Pharmaceuticals annual total current assets?
The current annual current assets of SNDX is $580.88 M
What is the all time high annual current assets for Syndax Pharmaceuticals?
Syndax Pharmaceuticals all-time high annual total current assets is $580.88 M
What is Syndax Pharmaceuticals annual current assets year-on-year change?
Over the past year, SNDX annual total current assets has changed by +$91.09 M (+18.60%)
What is Syndax Pharmaceuticals quarterly total current assets?
The current quarterly current assets of SNDX is $414.81 M
What is the all time high quarterly current assets for Syndax Pharmaceuticals?
Syndax Pharmaceuticals all-time high quarterly total current assets is $580.88 M
What is Syndax Pharmaceuticals quarterly current assets year-on-year change?
Over the past year, SNDX quarterly total current assets has changed by +$33.84 M (+8.88%)